…Weissman, this week our round-up highlights the importance of genetics, genomics and gene editing in drug discovery. You can listen below, or find The Drug Discovery World Podcast on Spotify,…
…dedicated to the treatment of sarcopenia in 2024. The advancement of our lead programme is paving the way for the expansion of the broader pipeline via our drug discovery platforms.”…
…Syndrome Therapeutics (FAST). The grant is intended to support the entire trajectory of drug development – from the proof-of-concept studies through to the IND-enabling studies required for a clinical trial…
…combination with a checkpoint inhibitor to treat SCLC in our upcoming Acclaim-3 clinical trial, where we have both FDA Fast Track and Orphan Drug Designations for this patient population.” No…
…scheme which makes the UK internationally competitive, so the country can be home to tomorrow’s medical breakthroughs.” Diana Spencer, Senior Digital Content Editor, Drug Discovery World References The Kings Fund,…
…role that it plays in unlocking new insight and accelerating drug discovery with AI. What you will learn: What are the benefits of AI in drug discovery? How can this…
…for creating therapeutics, Katalin Karikó and Drew Weissman, this week our round-up highlights the importance of genetics, genomics and gene editing in drug discovery. The top stories: mRNA pioneers Katalin…
A national total-body positron emission tomography (PET) imaging platform for drug discovery is launching in the UK next year. It is hoped that the National PET Imaging Platform (NPIP) will…
New research suggests that age-related macular degeneration (AMD) decreases an essential fatty acid, preventing the formation of a class of protective molecules and reducing repair potential – a discovery that…
Novavax has become the next company to have an updated version of its Covid-19 vaccine approved in the US. The Food and Drug Administration (FDA) amended the emergency use authorisation…
…be followed by a panel discussion addressing new drug discovery and development concepts and tools in cancer research, and how these new approaches – e.g. engineered proteins, antibodies, micro RNA,…
The webinar ‘Generative AI: Turning drug discovery into a technological pursuit’ supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT…
…the lab, the team tested a new genetic therapy to silence the overactive gene and a drug to block the CRAC channels. Both treatments were able to improve the calcium…
Watch this new webinar to embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug…
…into clinical use. 4SC is well positioned for realiszation of resminostat (Kinselby)’s considerable value through either a sale, licensing, or partnership agreement.” Resminostat was granted orphan drug designation (ODD) for…
Embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. This on-demand webinar shows…
